Shares of health-care companies were more or less flat amid merger activity.
Laboratory Corp. of America agreed to buy Chiltern International for $1.2 billion in a move to grow its stake in the drug development and contract-research niche.
Continue Reading Below
French drug maker Sanofi was more or less flat after it reported quarterly profit in line with analyst expectations and boosted its earnings projection for 2017.
-Rob Curran, email@example.com
(END) Dow Jones Newswires
July 31, 2017 16:44 ET (20:44 GMT)